Skip to main content
Top
Published in: BMC Psychiatry 1/2019

Open Access 01-12-2019 | Schizophrenia | Research article

Hazardous alcohol use in a sample of first episode psychosis patients in Singapore

Authors: Laxman Cetty, Shazana Shahwan, Pratika Satghare, Fiona Devi, Boon Yiang Chua, Swapna Verma, Helen Lee, Siow Ann Chong, Mythily Subramaniam

Published in: BMC Psychiatry | Issue 1/2019

Login to get access

Abstract

Background

Hazardous alcohol use has often been found to be more prevalent amongst psychiatric outpatients than the general population. Additionally, it has also been associated with poorer outcomes. The study aimed to investigate (1) the prevalence and (2) socio-demographic and clinical correlates of hazardous alcohol use, as well as (3) the relationship between hazardous alcohol use and quality of life in an outpatient sample with First Episode Psychosis (FEP) in Singapore.

Methods

Baseline data (N = 280) was extracted from a longitudinal study investigating smoking and alcohol use amongst outpatients with FEP in a psychiatric hospital. Information on socio-demographics, hazardous alcohol use, and quality of life was collected through a self-report survey. Hazardous alcohol use was ascertained by total scores of 8 or higher on the Alcohol Use Disorders Identification Test (AUDIT). Data was analysed using logistic regression and linear regression analyses.

Results

The prevalence of hazardous alcohol use over the past 12-month period was 12.9%. Those who had never smoked in their lifetime (vs current smokers) and those with a diagnosis of brief psychotic disorder (vs schizophrenia spectrum disorders) were found to have significantly lower odds of hazardous alcohol use. Hazardous alcohol use was also associated with lower negative symptom scores. Lastly, hazardous alcohol use was found to significantly predict lower scores on the physical health, social relationship and environment domains of quality of life.

Conclusions

The association between hazardous alcohol use and lower negative symptom scores is a surprising finding that needs to be further explored. The significant impact of hazardous alcohol use in reductions in quality of life suggests that early screening and interventions could benefit patients with hazardous alcohol use and comorbid psychosis.
Literature
1.
go back to reference American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Washington, DC: American Psychiatric Association; 2000. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Washington, DC: American Psychiatric Association; 2000.
2.
go back to reference American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
4.
go back to reference Saunders JB, Lee NK. Hazardous alcohol use: its delineation as a subthreshold disorder, and approaches to its diagnosis and management. Compr Psychiatry. 2000;41(2, Supplement 1):95–103.PubMed Saunders JB, Lee NK. Hazardous alcohol use: its delineation as a subthreshold disorder, and approaches to its diagnosis and management. Compr Psychiatry. 2000;41(2, Supplement 1):95–103.PubMed
5.
go back to reference Moyer A, Finney JW, Swearingen CE, Vergun P. Brief interventions for alcohol problems: a meta-analytic review of controlled investigations in treatment-seeking and non-treatment-seeking populations. Addiction. 2002;97(3):279–92.PubMed Moyer A, Finney JW, Swearingen CE, Vergun P. Brief interventions for alcohol problems: a meta-analytic review of controlled investigations in treatment-seeking and non-treatment-seeking populations. Addiction. 2002;97(3):279–92.PubMed
6.
go back to reference McCreadie RG. Use of drugs, alcohol and tobacco by people with schizophrenia: case-control study. Br J Psychiatry. 2002;181(4):321–5.PubMed McCreadie RG. Use of drugs, alcohol and tobacco by people with schizophrenia: case-control study. Br J Psychiatry. 2002;181(4):321–5.PubMed
7.
go back to reference Hartz SM, Pato CN, Medeiros H, Cavazos-Rehg P, Sobell JL, Genomic Psychiatry Cohort C, et al. Comorbidity of severe psychotic disorders with measures of substance use. JAMA Psych. 2014;71(3):248–54. Hartz SM, Pato CN, Medeiros H, Cavazos-Rehg P, Sobell JL, Genomic Psychiatry Cohort C, et al. Comorbidity of severe psychotic disorders with measures of substance use. JAMA Psych. 2014;71(3):248–54.
8.
go back to reference Etter M, Etter J-F. Alcohol consumption and the CAGE test in outpatients with schizophrenia or schizoaffective disorder and in the general population. Schizophr Bull. 2004;30(4):947–56.PubMed Etter M, Etter J-F. Alcohol consumption and the CAGE test in outpatients with schizophrenia or schizoaffective disorder and in the general population. Schizophr Bull. 2004;30(4):947–56.PubMed
9.
go back to reference Verma S, Poon LY, Subramaniam M, Abdin E, Chong SA. The Singapore Early Psychosis Intervention Programme (EPIP): a programme evaluation. Asian J Psychiatr. 2012;5(1):63–7. Verma S, Poon LY, Subramaniam M, Abdin E, Chong SA. The Singapore Early Psychosis Intervention Programme (EPIP): a programme evaluation. Asian J Psychiatr. 2012;5(1):63–7.
10.
go back to reference Álvarez-Jiménez M, Parker AG, Hetrick SE, McGorry PD, Gleeson JF. Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis. Schizophr Bull. 2011;37(3):619–30.PubMed Álvarez-Jiménez M, Parker AG, Hetrick SE, McGorry PD, Gleeson JF. Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis. Schizophr Bull. 2011;37(3):619–30.PubMed
11.
go back to reference Compton MT, Whicker NE, Hochman KM. Alcohol and Cannabis use in urban, African American, first-episode schizophrenia-spectrum patients: associations with positive and negative symptoms. J Clin Psychiatry. 2007;68(12):1939–45.PubMed Compton MT, Whicker NE, Hochman KM. Alcohol and Cannabis use in urban, African American, first-episode schizophrenia-spectrum patients: associations with positive and negative symptoms. J Clin Psychiatry. 2007;68(12):1939–45.PubMed
12.
go back to reference Osher FC, Drake RE, Noordsy DL, Teague GB, Hurlbut SC, Biesanz JC, et al. Correlates and outcomes of alcohol use disorder among rural outpatients with schizophrenia. J Clin Psychiatry. 1994;55(3):109–13.PubMed Osher FC, Drake RE, Noordsy DL, Teague GB, Hurlbut SC, Biesanz JC, et al. Correlates and outcomes of alcohol use disorder among rural outpatients with schizophrenia. J Clin Psychiatry. 1994;55(3):109–13.PubMed
13.
go back to reference Messias E, Bienvenu OJ. Suspiciousness and alcohol use disorders in schizophrenia. J Nerv Ment Dis. 2003;191(6):387–90.PubMed Messias E, Bienvenu OJ. Suspiciousness and alcohol use disorders in schizophrenia. J Nerv Ment Dis. 2003;191(6):387–90.PubMed
14.
go back to reference Lange EH, Nesvåg R, Ringen PA, Hartberg CB, Haukvik UK, Andreassen OA, et al. One year follow-up of alcohol and illicit substance use in first-episode psychosis: does gender matter? Compr Psychiatry. 2014;55(2):274–82.PubMed Lange EH, Nesvåg R, Ringen PA, Hartberg CB, Haukvik UK, Andreassen OA, et al. One year follow-up of alcohol and illicit substance use in first-episode psychosis: does gender matter? Compr Psychiatry. 2014;55(2):274–82.PubMed
15.
go back to reference Jones RM, Lichtenstein P, Grann M, Langstrom N, Fazel S. Alcohol use disorders in schizophrenia: a national cohort study of 12,653 patients. J Clin Psychiatry. 2011;72(6):775–9. Jones RM, Lichtenstein P, Grann M, Langstrom N, Fazel S. Alcohol use disorders in schizophrenia: a national cohort study of 12,653 patients. J Clin Psychiatry. 2011;72(6):775–9.
16.
go back to reference Cooper J, Mancuso SG, Borland R, Slade T, Galletly C, Castle D. Tobacco smoking among people living with a psychotic illness: the second Australian survey of psychosis. Aust N Z J Psychiatry. 2012;46(9):851–63.PubMed Cooper J, Mancuso SG, Borland R, Slade T, Galletly C, Castle D. Tobacco smoking among people living with a psychotic illness: the second Australian survey of psychosis. Aust N Z J Psychiatry. 2012;46(9):851–63.PubMed
17.
go back to reference Eberhard S, Nordstrom G, Ojehagen A. Hazardous alcohol use in general psychiatric outpatients. J Ment Health. 2015;24(3):162–7.PubMed Eberhard S, Nordstrom G, Ojehagen A. Hazardous alcohol use in general psychiatric outpatients. J Ment Health. 2015;24(3):162–7.PubMed
18.
go back to reference Archie S, Rush BR, Akhtar-Danesh N, Norman R, Malla A, Roy P, et al. Substance use and abuse in first-episode psychosis: prevalence before and after early intervention. Schizophr Bull. 2007;33(6):1354–63.PubMedPubMedCentral Archie S, Rush BR, Akhtar-Danesh N, Norman R, Malla A, Roy P, et al. Substance use and abuse in first-episode psychosis: prevalence before and after early intervention. Schizophr Bull. 2007;33(6):1354–63.PubMedPubMedCentral
19.
go back to reference Huang MC, Yu CH, Chen CT, Chen CC, Shen WW, Chen CH. Prevalence and identification of alcohol use disorders among severe mental illness inpatients in Taiwan. Psychiatry Clin Neurosci. 2009;63(1):94–100.PubMed Huang MC, Yu CH, Chen CT, Chen CC, Shen WW, Chen CH. Prevalence and identification of alcohol use disorders among severe mental illness inpatients in Taiwan. Psychiatry Clin Neurosci. 2009;63(1):94–100.PubMed
20.
go back to reference Kumar CN, Thirthalli J, Suresha KK, Arunachala U, Gangadhar BN. Alcohol use disorders in patients with schizophrenia: comparative study with general population controls. Addict Behav. 2015;45:22–5.PubMed Kumar CN, Thirthalli J, Suresha KK, Arunachala U, Gangadhar BN. Alcohol use disorders in patients with schizophrenia: comparative study with general population controls. Addict Behav. 2015;45:22–5.PubMed
21.
go back to reference Subramaniam M, Abdin E, Vaingankar J, Phua AM, Tee J, Chong SA. Prevalence and correlates of alcohol use disorders in the Singapore mental health survey. Addiction. 2012;107(8):1443–52.PubMed Subramaniam M, Abdin E, Vaingankar J, Phua AM, Tee J, Chong SA. Prevalence and correlates of alcohol use disorders in the Singapore mental health survey. Addiction. 2012;107(8):1443–52.PubMed
22.
go back to reference Tay A, Peh AL, Tan SN, Chan HN, Guo S, Chan YH. Alcohol use disorders amongst inpatients in a general hospital in Singapore: estimated prevalence, rates of identification and intervention. Ann Acad Med Singapore. 2016;45(4):138–47. Tay A, Peh AL, Tan SN, Chan HN, Guo S, Chan YH. Alcohol use disorders amongst inpatients in a general hospital in Singapore: estimated prevalence, rates of identification and intervention. Ann Acad Med Singapore. 2016;45(4):138–47.
23.
go back to reference Subramaniam M, Mahesh MV, Peh CX, Tan J, Fauziana R, Satghare P, et al. Hazardous alcohol use among patients with schizophrenia and depression. Alcohol. 2017;65:63–9.PubMed Subramaniam M, Mahesh MV, Peh CX, Tan J, Fauziana R, Satghare P, et al. Hazardous alcohol use among patients with schizophrenia and depression. Alcohol. 2017;65:63–9.PubMed
24.
go back to reference Cassidy CM, Schmitz N, Malla A. Validation of the alcohol use disorders identification test and the drug abuse screening test in first episode psychosis. Can J Psychiatr. 2008;53(1):26–33. Cassidy CM, Schmitz N, Malla A. Validation of the alcohol use disorders identification test and the drug abuse screening test in first episode psychosis. Can J Psychiatr. 2008;53(1):26–33.
25.
go back to reference The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28(3):551–8. The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28(3):551–8.
26.
go back to reference Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–76.PubMed Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–76.PubMed
27.
go back to reference Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. JAMA. 1990;264(19):2511–8.PubMed Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. JAMA. 1990;264(19):2511–8.PubMed
28.
go back to reference Khantzian EJ. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry. 1997;4(5):231–44.PubMed Khantzian EJ. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry. 1997;4(5):231–44.PubMed
29.
go back to reference Harris KM, Edlund MJ. Self-medication of mental health problems: new evidence from a National Survey. Health Serv Res. 2005;40(1):117–34.PubMedPubMedCentral Harris KM, Edlund MJ. Self-medication of mental health problems: new evidence from a National Survey. Health Serv Res. 2005;40(1):117–34.PubMedPubMedCentral
30.
go back to reference Pristach CA, Smith CM. Self-reported effects of alcohol use on symptoms of schizophrenia. Psychiatr Serv. 1996;47(4):421–3.PubMed Pristach CA, Smith CM. Self-reported effects of alcohol use on symptoms of schizophrenia. Psychiatr Serv. 1996;47(4):421–3.PubMed
31.
go back to reference Talamo A, Centorrino F, Tondo L, Dimitri A, Hennen J, Baldessarini RJ. Comorbid substance-use in schizophrenia: relation to positive and negative symptoms. Schizophr Res. 2006;86(1–3):251–5.PubMed Talamo A, Centorrino F, Tondo L, Dimitri A, Hennen J, Baldessarini RJ. Comorbid substance-use in schizophrenia: relation to positive and negative symptoms. Schizophr Res. 2006;86(1–3):251–5.PubMed
32.
go back to reference Batki SL, Leontieva L, Dimmock JA, Ploutz-Snyder R. Negative symptoms are associated with less alcohol use, craving, and "high" in alcohol dependent patients with schizophrenia. Schizophr Res. 2008;105(1–3):201–7.PubMedPubMedCentral Batki SL, Leontieva L, Dimmock JA, Ploutz-Snyder R. Negative symptoms are associated with less alcohol use, craving, and "high" in alcohol dependent patients with schizophrenia. Schizophr Res. 2008;105(1–3):201–7.PubMedPubMedCentral
33.
go back to reference Room R. Smoking and drinking as complementary Behaviours. Biomed Pharmacother. 2004;58(2):111–5.PubMed Room R. Smoking and drinking as complementary Behaviours. Biomed Pharmacother. 2004;58(2):111–5.PubMed
34.
go back to reference Picco L, Subramaniam M, Abdin E, Vaingankar JA, Chong SA. Smoking and nicotine dependence in Singapore: findings from a cross-sectional epidemiological study. Ann Acad Med Singapore. 2012;41(8):325–34.PubMed Picco L, Subramaniam M, Abdin E, Vaingankar JA, Chong SA. Smoking and nicotine dependence in Singapore: findings from a cross-sectional epidemiological study. Ann Acad Med Singapore. 2012;41(8):325–34.PubMed
35.
go back to reference Strawbridge RJ, Ward J, Cullen B, Tunbridge EM, Hartz S, Bierut L, et al. Genome-wide analysis of self-reported risk-taking behaviour and cross-disorder genetic correlations in the UK Biobank cohort. Transl Psychiatry. 2018;8(1):39. Strawbridge RJ, Ward J, Cullen B, Tunbridge EM, Hartz S, Bierut L, et al. Genome-wide analysis of self-reported risk-taking behaviour and cross-disorder genetic correlations in the UK Biobank cohort. Transl Psychiatry. 2018;8(1):39.
36.
go back to reference Hart CL, Davey Smith G, Gruer L, Watt GC. The combined effect of smoking tobacco and drinking alcohol on cause-specific mortality: a 30 year Cohort study. BMC Public Health. 2010;10(1):789.PubMedPubMedCentral Hart CL, Davey Smith G, Gruer L, Watt GC. The combined effect of smoking tobacco and drinking alcohol on cause-specific mortality: a 30 year Cohort study. BMC Public Health. 2010;10(1):789.PubMedPubMedCentral
37.
go back to reference World Health Organization. Global status report on alcohol and health. Geneva: World Health Organization; 2014. p. 2014. World Health Organization. Global status report on alcohol and health. Geneva: World Health Organization; 2014. p. 2014.
38.
go back to reference Roehrs T, Roth T. Sleep, sleepiness, sleep disorders and alcohol use and abuse. Sleep Med Rev. 2001;5(4):287–97.PubMed Roehrs T, Roth T. Sleep, sleepiness, sleep disorders and alcohol use and abuse. Sleep Med Rev. 2001;5(4):287–97.PubMed
39.
go back to reference Aas RW, Haveraaen L, Sagvaag H, Thørrisen MM. The influence of alcohol consumption on sickness presenteeism and impaired daily activities. The WIRUS screening study. PLoS One. 2017;12(10):e0186503. Aas RW, Haveraaen L, Sagvaag H, Thørrisen MM. The influence of alcohol consumption on sickness presenteeism and impaired daily activities. The WIRUS screening study. PLoS One. 2017;12(10):e0186503.
40.
go back to reference Drake RE, Mueser KT. Co-occurring alcohol use disorder and schizophrenia. Alcohol Res Health. 2002;26(2):99–101. Drake RE, Mueser KT. Co-occurring alcohol use disorder and schizophrenia. Alcohol Res Health. 2002;26(2):99–101.
41.
go back to reference Leonard KE, Eiden RD. Marital and family processes in the context of alcohol use and alcohol disorders. Annu Rev Clin Psychol. 2007;3:285–310.PubMedPubMedCentral Leonard KE, Eiden RD. Marital and family processes in the context of alcohol use and alcohol disorders. Annu Rev Clin Psychol. 2007;3:285–310.PubMedPubMedCentral
42.
go back to reference Bun Cheung Y, Yeo K, Joon Chong K, Yh Khoo E, Lin Wee H. Reliability and validity of the English-, Chinese- and Malay-language versions of the World Health Organization quality of life (WHOQOL-BREF) questionnaire in Singapore. Ann Acad Med Singapore. 2017;46(12):461–9. Bun Cheung Y, Yeo K, Joon Chong K, Yh Khoo E, Lin Wee H. Reliability and validity of the English-, Chinese- and Malay-language versions of the World Health Organization quality of life (WHOQOL-BREF) questionnaire in Singapore. Ann Acad Med Singapore. 2017;46(12):461–9.
44.
go back to reference Bahorik AL, Leibowitz A, Sterling SA, Travis A, Weisner C, Satre DD. The role of hazardous drinking reductions in predicting depression and anxiety symptom improvement among Psychiatry patients: a longitudinal study. J Affect Disord. 2016;206:169–73.PubMedPubMedCentral Bahorik AL, Leibowitz A, Sterling SA, Travis A, Weisner C, Satre DD. The role of hazardous drinking reductions in predicting depression and anxiety symptom improvement among Psychiatry patients: a longitudinal study. J Affect Disord. 2016;206:169–73.PubMedPubMedCentral
45.
go back to reference Reinert DF, Allen JP. The alcohol use disorders identification test (AUDIT): a review of recent research. Alcohol Clin Exp Res. 2002;26(2):272–9.PubMed Reinert DF, Allen JP. The alcohol use disorders identification test (AUDIT): a review of recent research. Alcohol Clin Exp Res. 2002;26(2):272–9.PubMed
46.
go back to reference Reinert DF, Allen JP. The alcohol use disorders identification test: an update of research findings. Alcohol Clin Exp Res. 2007;31(2):185–99.PubMed Reinert DF, Allen JP. The alcohol use disorders identification test: an update of research findings. Alcohol Clin Exp Res. 2007;31(2):185–99.PubMed
47.
go back to reference White AM. What happened? Alcohol, memory blackouts, and the Brain. Alcohol Res Health. 2003;27(2):186–96.PubMed White AM. What happened? Alcohol, memory blackouts, and the Brain. Alcohol Res Health. 2003;27(2):186–96.PubMed
Metadata
Title
Hazardous alcohol use in a sample of first episode psychosis patients in Singapore
Authors
Laxman Cetty
Shazana Shahwan
Pratika Satghare
Fiona Devi
Boon Yiang Chua
Swapna Verma
Helen Lee
Siow Ann Chong
Mythily Subramaniam
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Schizophrenia
Published in
BMC Psychiatry / Issue 1/2019
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-019-2073-z

Other articles of this Issue 1/2019

BMC Psychiatry 1/2019 Go to the issue